What one share of Cardiol Therapeutics holds
Cardiol Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.
| Profit | −$0.28 |
|---|---|
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.20 |
| Cash and investments | $0.16 |
| Book value | $0.13 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2020 | — | −$0.52 | $0.00 | −$0.23 | — | $0.35 |
| 2021 | $0.00 | −$0.58 | $0.00 | −$0.43 | — | $0.96 |
| 2022 | — | −$0.38 | $0.00 | −$0.34 | — | $0.60 |
| 2023 | — | −$0.32 | $0.00 | −$0.29 | — | $0.33 |
| 2024 | — | −$0.37 | $0.00 | −$0.26 | — | $0.21 |
| 2025 | — | −$0.28 | $0.00 | −$0.20 | — | $0.13 |
Common questions about Cardiol Therapeutics
How much does one share of Cardiol Therapeutics earn?
Over its latest fiscal year, Cardiol Therapeutics lost $0.28 for each share.
Does Cardiol Therapeutics pay a dividend?
Cardiol Therapeutics didn’t pay a dividend over its latest fiscal year, according to its SEC filings.
What is Cardiol Therapeutics’s book value per share?
Cardiol Therapeutics’s book value is $0.13 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of December 31, 2025.
How much cash and debt does each share of Cardiol Therapeutics have?
Each share of Cardiol Therapeutics has $0.16 of cash and investments, as of December 31, 2025.
What is Cardiol Therapeutics’s free cash flow per share?
−$0.20 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.
Has Cardiol Therapeutics bought back shares?
Cardiol Therapeutics’s share count rose about 191% from 2020 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.